Northwestern Mutual Wealth Management
CCCC icon

Northwestern Mutual Wealth Management’s C4 Therapeutics CCCC Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,628
Closed -$4.89K – 3496
2023
Q3 		$4.89K Hold
2,628
– – ﹤0.01% 2762
2023
Q2 		$7.23K Hold
2,628
– – ﹤0.01% 2667
2023
Q1 		$8.25K Hold
2,628
– – ﹤0.01% 2571
2022
Q4 		$15.5K Hold
2,628
– – ﹤0.01% 2344
2022
Q3 		$23K Hold
2,628
– – ﹤0.01% 2157
2022
Q2 		$20K Sell
2,628
-11,912
-82% -$105K ﹤0.01% 2244
2022
Q1 		$353K Buy
14,540
+8,120
+126% +$197K ﹤0.01% 1213
2021
Q4 		$207K Sell
6,420
-5,259
-45% -$208K ﹤0.01% 1422
2021
Q3 		$522K Buy
+11,679
New +$500K ﹤0.01% 972

Other funds holding CCCC

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northwestern Mutual Wealth Management's CCCC Position: Q4 2023 in Review

Northwestern Mutual Wealth Management sold out of C4 Therapeutics (CCCC) in Q4 2023, closing a stake of 2,628 shares — an estimated $4.89K sold.

Northwestern Mutual Wealth Management first reported a position in CCCC in Q3 2021 and held it in 9 quarters. The position peaked at $522K in Q3 2021. 92 funds tracked by Wall St. Rank hold CCCC as of Q4 2023.

  • Northwestern Mutual Wealth Management reported no remaining C4 Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 2,628 C4 Therapeutics shares in Q4 2023, an estimated $4.89K.
  • Northwestern Mutual Wealth Management first reported a position in C4 Therapeutics in Q3 2021 and held it in 9 quarters.
  • Northwestern Mutual Wealth Management's C4 Therapeutics position peaked at $522K in Q3 2021.
  • 92 funds tracked by Wall St. Rank held C4 Therapeutics as of Q4 2023.

Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2023, filed 13 Feb 2024.